A Follow-up Study to Evaluate the Efficacy and Safety of Novomax in Posterior Lumbar Interbody Fusion
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bong-Soon Chang, MD. PhD.
Seoul National University Hospital
Principal Investigator - Ho-Joong Kim, MD. PhD.
Seoul National University Bundang Hospital
Principal Investigator - Jae Hyup Lee, MD. PhD.
SMG-SNU Boramae Medical Center
Principal Investigator - Ki Hyoung Koo, MD. PhD.
DongGuk University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Oct 2010
- Primary completion
- 13 Sept 2013
- Completion
- 7 Apr 2016
- Last update posted
- 22 May 2018
- Registered enrollment
- 62
- Registry id
- NCT03532945
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.